Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Age-related Macular Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00499590
What this trial is testing

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD

Who this might be right for
Macular Degeneration
OPKO Health, Inc. 338
Post-approval studies (Phase 4)UnknownNCT02806752
What this trial is testing

Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy

Who this might be right for
Wet Macular Degeneration
Aier School of Ophthalmology, Central South University 120
Post-approval studies (Phase 4)WithdrawnNCT02634970
What this trial is testing

CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab

Who this might be right for
Wet Age-related Macular Degeneration (Wet AMD)
Novartis Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT01958918
What this trial is testing

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 712
Testing effectiveness (Phase 2)Study completedNCT03423823
What this trial is testing

Ziv-aflibercept Efficacy in Better Regulating AMD

Who this might be right for
Wet Macular DegenerationWet Age-related Macular Degeneration
Kapil Kapoor 62
Large-scale testing (Phase 3)UnknownNCT05727397
What this trial is testing

Efficacy and Safety of RC28-E Versus Aflibercept

Who this might be right for
Wet Age-related Macular Degeneration
RemeGen Co., Ltd. 432
Not applicableActive Not RecruitingNCT04420923
What this trial is testing

Optimizing the Treatment Strategy for Age-related Macular Degeneration

Who this might be right for
Wet Macular Degeneration
St. Olavs Hospital 250
Large-scale testing (Phase 3)UnknownNCT00454389
What this trial is testing

Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

Who this might be right for
Macular Degeneration
NeoVista 494
Testing effectiveness (Phase 2)Study completedNCT07501052
What this trial is testing

Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy

Who this might be right for
Neovascular (Wet) Age-Related Macular DegenerationRetinal Vein OcclusionDiabetic Macular Edema+1 more
Sam Chun Dang Pharm. Co. Ltd. 33
Not applicableStudy completedNCT02762188
What this trial is testing

Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)

Who this might be right for
Age-Related Macular Degeneration
Brugmann University Hospital 501
Not applicableStudy completedNCT05678517
What this trial is testing

Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMD

Who this might be right for
Age-Related Macular Degeneration
Semmelweis University 47
Not applicableUnknownNCT02747368
What this trial is testing

Evaluation of Visual Function and Driving Health Using Ocusweep in Patients Suffering From Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Turku University Hospital 600
Large-scale testing (Phase 3)Study completedNCT03844074
What this trial is testing

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration
Outlook Therapeutics, Inc. 61
Testing effectiveness (Phase 2)Ended earlyNCT00712491
What this trial is testing

Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Santen Inc. 20
Very early researchStudy completedNCT00517010
What this trial is testing

Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
University of California, Davis 6
Early research (Phase 1)WithdrawnNCT00538538
What this trial is testing

Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)

Who this might be right for
Retinal HemorrhageMacular Degeneration
Corewell Health East
Early research (Phase 1)Study completedNCT03748784
What this trial is testing

ADVM-022 Intravitreal Gene Therapy for Wet AMD

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 30
Large-scale testing (Phase 3)Study completedNCT00826371
What this trial is testing

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients

Who this might be right for
Age Related Macular Degeneration
Novartis Pharmaceuticals 114
Not applicableStudy completedNCT01245387
What this trial is testing

Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration

Who this might be right for
Macular DegenerationAge-related Macular DegenerationNeovascular Macular Degeneration
Pfizer 1,001
Large-scale testing (Phase 3)Ended earlyNCT01940887
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 645
Next Page